Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership

By Yahoo! Finance | Created at 2025-01-02 13:12:58 | Updated at 2025-01-08 22:01:02 6 days ago
Truth

Please enable JS and disable any ad blocker

Read Entire Article
  1. Homepage
  2. Business
  3. Sangamo Therapeutics Stock Plummets 56% After Pfizer Ends Hemophilia Treatment Partnership

Related

Stock market today: Dow, S&P 500 edge higher with Trump tariffs, jobs report in focus

Stock market today: Dow, S&P 500 edge higher with Trump tari...

52 minutes ago
Stowaways on planes and inside landing gear raise worries about aviation security

Stowaways on planes and inside landing gear raise worries ab...

1 hour ago
Rising Treasury yields prompt more US corporate bond issuance

Rising Treasury yields prompt more US corporate bond issuanc...

1 hour ago
Ski patrollers reach deal to end strike at Utah's Park City Mountain Resort

Ski patrollers reach deal to end strike at Utah's Park City ...

2 hours ago

Notice

News articles will be automatically deleted after one week.

Donate us by clicking here.

Popular

Unlawful border crossings dropped to four-year low in November, new data show

Unlawful border crossings dropped to four-year low in Novemb...

6 days ago
Children among 11 Killed in Israeli Attack on Gaza’s Khan Yunis

Children among 11 Killed in Israeli Attack on Gaza’s Khan Yu...

6 days ago
How Should the Western Press Cover Iran? 

How Should the Western Press Cover Iran? 

5 days ago
Islamic State Poster Shows Car Crushing Skulls: ‘Run Over Them Without Mercy’

Islamic State Poster Shows Car Crushing Skulls: ‘Run Over Th...

6 days ago
Moldova braces for energy crisis after Russia halts gas supply amid winter freeze

Moldova braces for energy crisis after Russia halts gas supp...

6 days ago
About Us · About Sources · Contact Us · Request a News Source · RSS · Donate · List of News Sources ·

© DevEvil News 2025. All rights are reserved, All content on this website, including articles, images, and logos sourced from external RSS feeds, as well as original content produced by DevEvil News, is protected by copyright law.